FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention relates to new compounds of the formula (I) where R1 and R2 each independently means chlorine, bromine, iodine atoms or a group OSO2Me; R1a and R2b - hydrogen atom; R3 and R4 - hydrogen atom; R5a and R5b - hydrogen atom, C1-4-alkyl, haloid; R5a and R5b form -CH=CH-CH=CH-; R5c and R5d - hydrogen atom, cyano-group, haloid; X means O, NH, -CH2-; Y means O; Z means -V-W where V means -CH2T- where T means -CH2- or -S-; W means COOH, -(C=O)NR7R8 where R7 - hydrogen atom, C1-6-alkyl and the others; R8 - hydrogen atom and their salts. Method of synthesis of compounds of the formula (I) involves removal of protection in compound of the formula (Ia) . Invention proposes a pharmaceutical composition containing an effective amount of compound of the formula (I) and a bicomponent system for delivery of cytotoxic drug consisting of antibody or its fragment which are able to bind a definite antigen. Antigen or its fragment are conjugated with an enzyme CPG which is able to convert a compound of the formula (I) or its salt to a cytotoxic drug and has additionally a compound of the formula (I) or its salt which are converted to a cytotoxic drug by an enzyme CPG effect. EFFECT: improved method of synthesis and drug delivery. 16 cl, 12 dwg, 18 tbl, 46 ex
Title |
Year |
Author |
Number |
QUINAZOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1993 |
- Stiven Dzhon Pegg[Gb]
- Dzhejms Majkl Vordlvert[Gb]
|
RU2111209C1 |
DERIVATIVES OF QUINAZOLINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION BASED ON SAID |
1993 |
|
RU2127263C1 |
QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF VESSEL ENDOTHELIUM GROWTH FACTOR |
1997 |
- Tomas Ehndrju Peter
- Dzhonstoun Krehjg
- Ehnnekehn Loran Fransua Andre
|
RU2196137C2 |
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
1996 |
|
RU2198878C2 |
CARBOPENEM DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND HYDROLYZED IN VIVO ESTERS (VARIANTS), METHOD OF SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY, DERIVATIVES OF PYRROLIDINE-4-YLTHIOL AND PROTECTED DERIVATIVES OF PYRROLIDINE-4-YLTHIOL |
1993 |
- Majkl Dzhon Betts
- Garet Mors Dehvis
- Majkl Lingard Svejn
|
RU2117659C1 |
QUINAZOLINE DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND A METHOD FOR REACHING ANTIPROLIFERATIVE EFFECTS |
1996 |
|
RU2153495C2 |
DERIVATIVES OF QUINAZOLINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND METHOD OF ACHIEVEMENT OF ANTI-ANGIOGENIC EFFECT AND/OR EFFECT OF DECREASE OF VASCULAR PENETRATION WITH THEIR USING |
1996 |
- Lomann Zhan-Zhak Marsel'
- Ehnneken Loran Fransua Andre
- Tomas Ehndrju Piter
|
RU2194701C2 |
COMPATIBLE TWO-COMPONENT SYSTEM DESIGNATED FOR APPLICATION IN MAMMAL-HOST AS MEDICINAL AGENT (VARIANTS), METHOD FOR DELIVERY OF CYTOTOXIC DRUG |
1998 |
- Ehmeri Stefen Charl'Z
- Blehjki Dehvid Charl'Z
|
RU2218404C2 |
DERIVATIVES OF N-HETEROARYLPYRIDINESULFONEAMIDE, METHODS OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF COUNTERACTION TO ONE OR MORE EFFECTS OF ENDOTHELIN |
1996 |
- Robert Kh'Ju Brehdberi
- Rodzher Dzhon Batlin
- Rodzher Dzhejms
|
RU2172738C2 |
SUBSTITUTED HETEROCYCLIC COMPOUNDS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, METHOD OF CONTROL OVER WEEDS |
1993 |
- Jan Trevor Kej
- Dzhon Ehdvard Dunkan Barton
- Dehvid Dzhon Kollinz
- Bogdan Koval'Chik
- Glinn Mitchell
- Dzhon Martin Shribbz
- Dzhon Majkl Koks
- Najdzhel Dzhon Barnz
- Stiven Kristofer Smit
|
RU2125050C1 |